Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
about
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringReview of functional/anatomical imaging in oncology.Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTAutomated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.
P2860
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@ast
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@en
type
label
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@ast
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@en
prefLabel
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@ast
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@en
P2093
P2860
P921
P1433
P1476
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
@en
P2093
David Cameron
Ian N Fleming
Ken A Miles
P2860
P304
P356
10.1102/1470-7330.2010.0020
P577
2010-07-06T00:00:00Z